These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22144668)

  • 1. Antiplatelet efficacy of long-term treatment with clopidogrel besylate in patients with a history of acute coronary syndrome: comparison with clopidogrel hydrogen sulfate.
    Tsoumani ME; Kalantzi KI; Dimitriou AA; Ntalas IV; Goudevenos IA; Tselepis AD
    Angiology; 2012 Oct; 63(7):547-51. PubMed ID: 22144668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of clopidogrel besylate on platelet reactivity in patients with acute coronary syndromes. Comparison with clopidogrel hydrogen sulfate.
    Tsoumani ME; Kalantzi KI; Dimitriou AA; Ntalas IV; Goudevenos IA; Tselepis AD
    Expert Opin Pharmacother; 2012 Feb; 13(2):149-58. PubMed ID: 22188544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of clopidogrel besylate and clopidogrel hydrogensulfate on platelet aggregation in patients with coronary artery disease: a retrospective study.
    Borsiczky B; Sarszegi Z; Konyi A; Szabados S; Gaszner B
    Thromb Res; 2012 Jun; 129(6):700-3. PubMed ID: 21924759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomised, double-blind ACAPULCO study.
    Montalescot G; Sideris G; Cohen R; Meuleman C; Bal dit Sollier C; Barthélémy O; Henry P; Lim P; Beygui F; Collet JP; Marshall D; Luo J; Petitjean H; Drouet L
    Thromb Haemost; 2010 Jan; 103(1):213-23. PubMed ID: 20062936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenergic receptor polymorphisms and platelet reactivity after treatment with dual antiplatelet therapy with aspirin and clopidogrel in acute coronary syndrome.
    Cuisset T; Hamilos M; Delrue M; Frère C; Verhamme K; Bartunek J; Saut N; Bonnet JL; Eijgelsheim M; Wijns W; Alessi MC; Barbato E
    Thromb Haemost; 2010 Apr; 103(4):774-9. PubMed ID: 20135061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the antiplatelet effect of clopidogrel hydrogenosulfate and clopidogrel besylate in patients with stable coronary artery disease.
    Hamilos M; Saloustros I; Skalidis E; Igoumenidis N; Kambouris M; Chlouverakis G; Vougia D; Loggakis I; Vardas PE; Kochiadakis G
    J Thromb Thrombolysis; 2015 Oct; 40(3):288-93. PubMed ID: 25662861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The platelet hyporesponsiveness to clopidogrel in acute coronary syndrome patients treated with 75 mg/day clopidogrel may be overcome within 1 month of treatment.
    Kalantzi KI; Dimitriou AA; Goudevenos JA; Tselepis AD
    Platelets; 2012; 23(2):121-31. PubMed ID: 21806493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.
    Storey RF; Husted S; Harrington RA; Heptinstall S; Wilcox RG; Peters G; Wickens M; Emanuelsson H; Gurbel P; Grande P; Cannon CP
    J Am Coll Cardiol; 2007 Nov; 50(19):1852-6. PubMed ID: 17980251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the antiplatelet effect of clopidogrel hydrogensulfate and clopidogrel besylate: a crossover study.
    Neubauer H; Krüger JC; Lask S; Endres HG; Pepinghege F; Engelhardt A; Bulut D; Mügge A
    Clin Res Cardiol; 2009 Sep; 98(9):533-40. PubMed ID: 19504141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV; Papathanasiou AI; Rodis FI; Elisaf M; Goudevenos JA; Tselepis AD
    Circulation; 2004 Mar; 109(11):1335-8. PubMed ID: 15023882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).
    Patti G; Pasceri V; Vizzi V; Ricottini E; Di Sciascio G
    Am J Cardiol; 2011 Apr; 107(7):995-1000. PubMed ID: 21256470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generic Clopidogrel Besylate in the Secondary Prevention of Atherothrombotic Events: A 6-month Follow-up of a Randomised Clinical Trial.
    Ntalas IV; Kalantzi KI; Tsoumani ME; Vakalis JN; Vasilakopoulos V; Vardakis K; Vemmos KN; Voukelatou M; Giannakoulas G; Giatrakos I; Giogiakas V; Goumas G; Dimoulis N; Draganigos A; Efthimiadis I; Thoma M; Kazakos E; Kipouridis N; Konstantinou S; Bourdakis A; Nikolopoulos D; Peltekis L; Prokopakis N; Sinteles I; Stroumbis CS; Terzoudi K; Tsilias K; Xaraktsis I; Charmpas C; Hatziathanasiou G; Christogiannis Z; Panagiotakos DB; Goudevenos JA; Tselepis AD
    Curr Vasc Pharmacol; 2015; 13(6):809-18. PubMed ID: 25782408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between initial and chronic response to clopidogrel therapy after coronary stenting for acute coronary syndrome and influence on clinical outcomes.
    Cuisset T; Quilici J; Loosveld M; Gaborit B; Grosdidier C; Fourcade L; Gil JM; Moro PJ; Morange PE; Bonnet JL; Alessi MC
    Am Heart J; 2012 Sep; 164(3):327-33. PubMed ID: 22980298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualised assessment of response to clopidogrel in patients presenting with acute coronary syndromes: a role for short thrombelastography?
    Cotton JM; Worrall AM; Hobson AR; Smallwood A; Amoah V; Dunmore S; Nevill AM; Raghuraman RP; Vickers J; Curzen N
    Cardiovasc Ther; 2010 Jun; 28(3):139-46. PubMed ID: 20406238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual antiplatelet drug resistance in patients with acute coronary syndrome.
    Guha S; Sardar P; Guha P; Roy S; Mookerjee S; Chakrabarti P; Deb PK; Chaudhuri U; Deb S; Karmakar R; Dasgupta AK; Lahiri P
    Indian Heart J; 2009; 61(1):68-73. PubMed ID: 19729693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salts of Clopidogrel: Investigation to Ensure Clinical Equivalence: A 12-Month Randomized Clinical Trial.
    Ntalas IV; Kalantzi KI; Tsoumani ME; Bourdakis A; Charmpas C; Christogiannis Z; Dimoulis N; Draganigos A; Efthimiadis I; Giannakoulas G; Giatrakos I; Giogiakas V; Goumas G; Hatziathanasiou G; Kazakos E; Kipouridis N; Konstantinou S; Milionis H; Nikolopoulos D; Peltekis L; Prokopakis N; Sinteles I; Stroumbis C; Terzoudi K; Thoma M; Tsilias K; Vakalis I; Vardakis K; Vasilakopoulos V; Vemmos K; Voukelatou M; Xaraktsis I; Panagiotakos DB; Goudevenos JA; Tselepis AD
    J Cardiovasc Pharmacol Ther; 2016 Nov; 21(6):516-525. PubMed ID: 27081185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aprotinin reduces the antiplatelet effect of clopidogrel.
    Lindvall G; Sartipy U; Bjessmo S; Svenarud P; Lindvall B; van der Linden J
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):178-81. PubMed ID: 19477870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple electrode aggregometry and vasodilator stimulated phosphoprotein-phosphorylation assay in clinical routine for prediction of postprocedural major adverse cardiovascular events.
    Freynhofer MK; Brozovic I; Bruno V; Farhan S; Vogel B; Jakl G; Willheim M; Hübl W; Wojta J; Huber K
    Thromb Haemost; 2011 Aug; 106(2):230-9. PubMed ID: 21614416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slow response to clopidogrel predicts low response.
    Bellemain-Appaix A; Montalescot G; Silvain J; Barthélémy O; Beygui F; Collet JP; Sideris G; Meuleman C; Bal-Dit-Sollier C; Lellouche N; Ducrocq G; Slama M; Milleron O; Henry P; Drouet L;
    J Am Coll Cardiol; 2010 Feb; 55(8):815-22. PubMed ID: 20170822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting.
    Cuisset T; Frere C; Quilici J; Morange PE; Nait-Saidi L; Carvajal J; Lehmann A; Lambert M; Bonnet JL; Alessi MC
    J Am Coll Cardiol; 2006 Oct; 48(7):1339-45. PubMed ID: 17010792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.